Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 7Recruiting 3Active not recruiting 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1

Conditions

Tobacco Use 1Smoking Cessation 1Lung Neoplasms 1

Interventions

pembrolizumab 436Carboplatin 321Nivolumab 287Cyclophosphamide 280Specimen Handling 257Cisplatin 251Paclitaxel 248Magnetic Resonance Spectroscopy 248Radiotherapy 217Gemcitabine 180Dexamethasone 180Biopsy 177durvalumab 166atezolizumab 148Rituximab 138Lenalidomide 134Doxorubicin 134Docetaxel 130Bevacizumab 129Ipilimumab 125Radiation 118Capecitabine 117Pemetrexed 112Oxaliplatin 112Etoposide 111Radiosurgery 108Fluorouracil 108venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Nicotine Replacement Therapy × Clear all
NCT05144542 2026-04-15

Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
140 enrolled
Thoracic

Lung Neoplasms

NCT03315910 2025-11-24

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Memorial Sloan Kettering Cancer Center

Phase 4 Active not recruiting
807 enrolled

Smoking Cessation

NCT00575718 2025-10-10

Smoking Cessation Intervention for Cancer Patients

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
204 enrolled

Tobacco Use

Data powered by HemOnc (CC BY 4.0) Colophon âš¡